DEEJ东阿阿胶品牌怎么样 申请店铺

我要投票 DEEJ东阿阿胶在礼品行业中的票数:745 更新时间:2026-02-08
DEEJ东阿阿胶是哪个国家的品牌?「DEEJ东阿阿胶」是 东阿阿胶股份有限公司 旗下著名品牌。该品牌发源于山东省聊城市,由创始人秦玉峰在1952年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力DEEJ东阿阿胶品牌出海!将品牌入驻外推网,定制DEEJ东阿阿胶品牌推广信息,可以显著提高DEEJ东阿阿胶产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

DEEJ东阿阿胶怎么样

历史沿革:东阿阿胶股份有限公司隶属央企华润集团,前身为山东东阿阿胶厂,1952年建厂,1993年由国有企业改组为股份制企业。1996年成为上市公司,同年7月29日“东阿阿胶”A股股票在深交所挂牌上市。

系国家高新技术企业、国家级创新型企业、国家胶类中药工程技术研究中心、国家胶类中药标准制定者,国家综合性新药研发技术大平台产业化示范企业,国家级非物质文化遗产东阿阿胶制作技艺代表性传承人企业。

经营绩效:“东阿”牌阿胶在全国阿胶厂家中唯一3次荣膺国家金质奖、唯一荣获传统药“长城”国际金奖;上海世博会“千年金奖和“全国用户满意产品”称号;唯一8次入围“中国500最具价值品牌”;荣获首批300家“全国重点保护品牌”;“中国科技名牌500强”;影响世界中国力量品牌500强;中国行业标志性品牌;“最受消费者信赖保健品品牌”;“最具放心企业和最具放心品牌”;在国内十大补血品牌中,第一提及率、最常服用率、尝试率、品牌忠诚度等7项指标高居榜首。品牌价值106.05亿。

全国阿胶厂家唯一荣获2013国家质量奖提名奖,全省唯一企业及经营者双获省长质量奖,为中华老字号;“东阿”和“吉祥云”两个商标均为驰名保护;率先在全国同行业通过GMP、ISO9001质量体系、ISO14001国际环境体系三认证,跨入全国医药百强、全国科技百强、全国中药行业效益十佳企业;中国最具生命力的企业百强;连续7次入围“中国最具发展力上市公司50强”;连续六届蝉联中国药品品牌榜补益类第一名;连续四届入围中国最具竞争力医药上市公司20强;“最佳内部公司治理”;“最具价值医药上市公司10强”;“2013中国上市公司内部控制百强企业”;荣获全国中药行业排头兵;全国信息化融合50强;最佳雇主企业;全国科普教育基地;中国医药质量管理明星。

阿胶生物科技园是东阿阿胶股份有限公司“十二五”重点项目,占地512亩,建成后年总产值100亿元,利税30亿元。

该项目由美国5+design公司规划,集生产、物流、工业旅游、体验等服务功能于一体。项目达产实现三高三低:“三高”即:高标准(中国、美欧cGMP标准,产品质量标准领先行业20年)、高品质(在线检测)、高回报(产值利税率40%);“三低”:低能耗(光伏发电5兆瓦,满足园区50%用电,低温提取浓缩技术,万元产值综合能耗68公斤标煤,均为全国行业领先)、低排放(污水90%循环、药渣利用)、低污染。生产车间参照国家新版GMP、美国FDA和欧盟GMP标准设计,旅游按5A级工业旅游景区环境标准设计,车间内参观路线以科普走廊形式,展示阿胶文化和产品知识。

项目为全国阿胶厂家唯一、行业领先水平。项目建成后与东阿阿胶城一起,成为东阿阿胶进军集旅游、养生体验、中药生物药制造销售等全产业链的大健康产业基地。

History: dong'a-jiao Co., Ltd. is subordinate to the central enterprise China Resources Group, formerly Shandong dong'a-jiao factory, which was established in 1952 and reorganized from a state-owned enterprise to a joint-stock enterprise in 1993. In 1996, it became a listed company. On July 29 of the same year, "dong'a-jiao" A shares were listed on Shenzhen Stock Exchange. It is a national high-tech enterprise, national innovative enterprise, national rubber traditional Chinese Medicine Engineering Technology Research Center, national rubber traditional Chinese medicine standard setter, national comprehensive new drug R & D technology large platform industrialization demonstration enterprise, national intangible cultural heritage dong'a gum production technology representative inheritor enterprise. Business performance: "dong'a" brand Ejiao has won the national gold medal for three times and the international gold medal of traditional medicine "Great Wall" for the only three times among Ejiao manufacturers in China; the "Millennium gold medal" and "national user satisfaction product" for Shanghai World Expo; the only eight times "China's 500 most valuable brands"; the first 300 "national key protection brands"; and "China's top 500 science and technology brands" Among the top ten blood toning brands in China, the first mentioned rate, the most frequently used rate, the trial rate and the brand loyalty rank first in the list. The brand value is 10.605 billion. The only Ejiao manufacturer in China won the 2013 National Quality Award nomination award, the only enterprise and operator in the province won the provincial governor's quality award, which is a time-honored Chinese brand; "dong'a" and "Ji Xiangyun" are well-known protection trademarks; it took the lead in passing the three certifications of GMP, ISO9001 quality system and ISO14001 international environmental system in the same industry in the country, and entered the top 100 medicine, science and technology and the whole country Top 10 enterprises in the benefits of traditional Chinese medicine industry; top 100 enterprises with the most vitality in China; 7 times in a row to be shortlisted as "top 50 listed companies with the most development power in China"; 6 times in a row to be the No. 1 in the category of complementary benefits in China's pharmaceutical brand list; 4 times in a row to be shortlisted as the top 20 most competitive pharmaceutical listed companies in China; "best internal corporate governance"; "top 10 most valuable pharmaceutical listed companies"; "mid-2013" Top 100 enterprises of internal control of Listed Companies in China; won the title of national leader in traditional Chinese medicine industry; top 50 enterprises of national information integration; best employer enterprise; national popular science education base; star of Chinese medicine quality management. Ejiao Biotechnology Park is a key project of the 12th Five Year Plan of dong'ejiao Co., Ltd., covering an area of 512 mu, with an annual output value of 10 billion yuan and a profit and tax of 3 billion yuan. The project is planned by 5 + design company of the United States, integrating production, logistics, industrial tourism, experience and other service functions. The project achieves three highs and three lows: high standard (cGMP standard of China, the United States and Europe, leading the industry in product quality standard for 20 years), high quality (online detection), high return (profit and tax rate of output value is 40%); "three lows": low energy consumption (photovoltaic power generation of 5 MW, meeting 50% of the park's electricity consumption, low-temperature extraction and concentration technology, comprehensive energy consumption of RMB 10000 output value of 68kg standard coal, all of which are full China's leading industry, low emissions (90% of sewage circulation, chemical residue utilization), low pollution. The production workshop is designed with reference to the new national GMP, American FDA and EU GMP standards. The tourism is designed according to the environmental standards of 5A level industrial tourism scenic spot. The tour route in the workshop is in the form of science popularization corridor to show the culture and product knowledge of donkey hide gelatin. The project is the only Ejiao manufacturer in China, leading in the industry. After the completion of the project, together with dong'a Jiaocheng, it will become a large health industrial base for dong'a Jiaocheng to enter the whole industrial chain, including tourism, health care experience, traditional Chinese medicine and biological medicine manufacturing and sales.

本文链接: https://brand.waitui.com/2018d2947.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

安路科技:第四大股东国家大基金等7家股东拟合计减持不超4%公司股份

2月8日,安路科技公告称,公司于近日收到股东国家大基金、安芯合伙、安路芯合伙、芯添合伙、深圳思齐、士兰微、士兰创投分别出具的关于股份减持计划的告知函,国家大基金拟减持不超过801.7万股,占公司总股本的比例不超过2%。安芯合伙拟减持不超过365.27万股,占公司总股本的比例不超过0.91%;安路芯合伙拟减持不超过14.81万股,拟占公司总股本的比例不超过0.0369%;芯添合伙拟减持不超过20.77万股,占公司总股本的比例合计不超过0.05%。深圳思齐拟减持不超过200.42万股,占公司总股本的比例合计不超过0.50%。士兰微拟减持不超过100.21万股,占公司总股本的比例合计不超过0.25%;士兰创投拟减持不超过100.21万股,占公司总股本的比例合计不超过0.25%。(财联社)

2小时前

中信证券:短期利益和长期价值的矛盾在海外市场激化

中信证券研报认为,近期海外市场风险偏好和流动性出现了明显异动。无论是战略安全的投入还是代表未来的新兴基建和技术投入,都意味着欧美将面临更激烈的竞争,同时面临短期股东利益和长期基础设施投入战略价值的权衡,矛盾在资本市场会反复被激发。对于长期习惯于赚“容易的钱”的投资者而言,未来全球金融市场的不确定性将持续提高,过度基于远期现金流或是资金接力预期的风险资产更容易出现持续的估值修正。反观中国的资本市场,过去几年已经先行完成了“脱虚向实”的定价,正处于对“提质增效”的验证和定价过程中,无需焦虑短期市场波动。配置上,建议依旧维持“资源+传统制造”打底,低吸非银,增配消费链和地产链。(证券时报)

2小时前

湖南白银:董事荣起因工作调整原因辞职

2月8日,湖南白银公告称,公司董事荣起因工作调整原因,申请辞去公司第六届董事会董事及董事会战略委员会委员的职务。辞职后荣起将不再担任公司任何职务。(每日经济新闻)

2小时前

国联民生:拟向民生证券增资2亿元

2月8日,国联民生公告,公司拟向民生证券增资2亿元,增资后公司对民生证券持股比例不变。本次增资的资金来源为公司向特定对象发行股票募集的配套资金,用于民生证券财富管理业务发展和信息技术投入。(第一财经)

2小时前

明冠新材:终止太阳能背板及功能性膜生产基地项目投资协议

2月8日,明冠新材公告,公司决定终止与肥东县人民政府签订的太阳能背板及功能性膜生产基地项目投资合作协议。该项目总投资预计50亿元,目前公司正积极配合肥东县政府办理定制物业的竣工验收等后续工作。自2023年第四季度起,光伏行业已出现产能过剩苗头,产业链产品价格竞争随之加剧,行业处于产业调整周期,2024年和2025年度出现光伏行业普遍亏损。公司管理层在对市场变化认真分析及谨慎研判的基础上,考虑行业内卷导致光伏封装材料盈利能力逐步下降,加之2025年行业竞争白热化且周期性调整尚未呈现明显好转,若继续推进明冠合肥项目,将不可避免地推高公司整体运营成本。(界面新闻)

2小时前

本页详细列出关于DEEJ东阿阿胶的品牌信息,含品牌所属公司介绍,DEEJ东阿阿胶所处行业的品牌地位及优势。
咨询